{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:15:30Z","timestamp":1768990530080,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T00:00:00Z","timestamp":1462147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00467-016-3369-6","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T11:00:48Z","timestamp":1462186848000},"page":"1615-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Atypical hemolytic uremic syndrome: a clinical conundrum"],"prefix":"10.1007","volume":"31","author":[{"given":"Prabesh","family":"Bajracharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Baracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tej K.","family":"Mattoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,2]]},"reference":[{"key":"3369_CR1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","volume":"290","author":"H Trachtman","year":"2003","unstructured":"Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290:1337\u20131344","journal-title":"JAMA"},{"key":"3369_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","volume":"24","author":"G Ariceta","year":"2009","unstructured":"Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24:687\u2013696","journal-title":"Pediatr Nephrol"},{"key":"3369_CR3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-013-2423-x","volume":"28","author":"L Rees","year":"2013","unstructured":"Rees L (2013) Atypical HUS: time to take stock of current guidelines and outcome measures? Pediatr Nephrol 28:675\u2013677","journal-title":"Pediatr Nephrol"},{"key":"3369_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00431-009-1039-4","volume":"169","author":"J Scheiring","year":"2010","unstructured":"Scheiring J, Rosales A, Zimmerhackl LB (2010) Clinical practice. Today\u2019s understanding of the haemolytic uraemic syndrome. Eur J Pediatr 169:7\u201313","journal-title":"Eur J Pediatr"},{"key":"3369_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"3369_CR6","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392\u20132400","journal-title":"J Am Soc Nephrol"},{"key":"3369_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","volume":"26","author":"AM Waters","year":"2011","unstructured":"Waters AM, Licht C (2011) aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol 26:41\u201357","journal-title":"Pediatr Nephrol"},{"key":"3369_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423\u2013431","journal-title":"Kidney Int"},{"key":"3369_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fremeaux-Bacchi V (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"3369_CR10","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","volume":"29","author":"S Johnson","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM (2014) An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol 29:1967\u20131978","journal-title":"Pediatr Nephrol"},{"key":"3369_CR11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/B978-1-4160-4044-6.50119-9","volume-title":"Textbook of pediatric infectious diseases","author":"AA Berry","year":"2009","unstructured":"Berry AA, Velarde JJ, Nataro JP (2009) Diarrhea-causing and dysentery causing Escherichia coli. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Textbook of pediatric infectious diseases, 6th edn. Wiley, Philadelphia, pp 1525\u20131540","edition":"6"},{"key":"3369_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/162.2.553","volume":"162","author":"PI Tarr","year":"1990","unstructured":"Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO (1990) Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 162:553\u2013556","journal-title":"J Infect Dis"},{"key":"3369_CR13","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/JCM.01231-14","volume":"52","author":"EI Schindler","year":"2014","unstructured":"Schindler EI, Sellenriek P, Storch GA, Tarr PI, Burnham CA (2014) Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. J Clin Microbiol 52:3647\u20133653","journal-title":"J Clin Microbiol"},{"key":"3369_CR14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 34:571\u2013590","journal-title":"Pediatr Clin N Am"},{"key":"3369_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"3369_CR16","unstructured":"Kidney Disease Outcomes Quality Initiative (2002) KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. IV. Definition and classification of stages of chronic kidney disease. Available at: http:\/\/www2.kidney.org\/professionals\/kdoqi\/guidelines_ckd\/p4_class.htm"},{"key":"3369_CR17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/319269","volume":"183","author":"N Banatvala","year":"2001","unstructured":"Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG (2001) The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063\u20131070","journal-title":"J Infect Dis"},{"key":"3369_CR18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archpediatrics.2012.471","volume":"166","author":"RK Mody","year":"2012","unstructured":"Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM, Griffin PM (2012) Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli. Arch Pediatr Adolesc Med 166:902\u2013909","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3369_CR19","unstructured":"Cincinnati Children\u2019s Hospital. Thrombotic microangiopathy. Available at: http:\/\/www.cincinnatichildrens.org\/service\/t\/thrombotic-microangiopathy\/tests . Accessed 6 January 2016"},{"key":"3369_CR20","unstructured":"Machaon Diagnostics. aHUS panel. Available at: http:\/\/www.machaondiagnostics.com\/panel\/ahus-genetic-panel\/ . Accessed 6 January 2016"},{"key":"3369_CR21","unstructured":"University of Iowa Carver College of Medicine. Molecular Otorhinolaryngology and Renal research laboratories. Available at: http:\/\/www.medicine.uiowa.edu\/morl\/tmapricing . Accessed 6 January 2016"},{"key":"3369_CR22","unstructured":"Blood Center of Wisconsin. aHUS\/DDD genetic evaluation. Available at: www.bcw.edu\/cs\/groups\/public\/documents\/documents\/zxrp\/y19l\/~edisp\/ahus_genetic_eval.pdf . Accessed 6 January 2016"},{"key":"3369_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00467-011-2067-7","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ (2012) Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective. Pediatr Nephrol 27:161\u2013164","journal-title":"Pediatr Nephrol"},{"key":"3369_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(96)70361-X","volume":"128","author":"RL Siegler","year":"1996","unstructured":"Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB (1996) Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr 128:505\u2013511","journal-title":"J Pediatr"},{"key":"3369_CR25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00467-010-1708-6","volume":"26","author":"SI Al-Akash","year":"2011","unstructured":"Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C (2011) Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol 26:613\u2013619","journal-title":"Pediatr Nephrol"},{"key":"3369_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2013.07.011","volume":"63","author":"F Fakhouri","year":"2014","unstructured":"Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Chatelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Fremeaux-Bacchi V (2014) Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases. Am J Kidney Dis 63:40\u201348","journal-title":"Am J Kidney Dis"},{"key":"3369_CR27","doi-asserted-by":"crossref","first-page":"e1385","DOI":"10.1542\/peds.2011-1685","volume":"130","author":"M Giordano","year":"2012","unstructured":"Giordano M, Castellano G, Messina G, Divella C, Bellantuono R, Puteo F, Colella V, Depalo T, Gesualdo L (2012) Preservation of renal function in atypical hemolytic uremic syndrome by eculizumab: a case report. Pediatrics 130:e1385\u2013e1388","journal-title":"Pediatrics"},{"key":"3369_CR28","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P, Schaefer F (2011) Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364:2561\u20132563","journal-title":"N Engl J Med"},{"key":"3369_CR29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nurnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"3369_CR30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","volume":"87","author":"C Licht","year":"2015","unstructured":"Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, Delmas Y, Douglas K, Furman RR, Gaber OA, Goodship T, Herthelius M, Hourmant M, Legendre CM, Remuzzi G, Sheerin N, Trivelli A, Loirat C (2015) Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int 87:1061\u20131073","journal-title":"Kidney Int"},{"key":"3369_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2012.07.028","volume":"61","author":"J Schmidtko","year":"2013","unstructured":"Schmidtko J, Peine S, El-Housseini Y, Pascual M, Meier P (2013) Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis 61:289\u2013299","journal-title":"Am J Kidney Dis"},{"key":"3369_CR32","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00467-012-2276-8","volume":"27","author":"R Vilalta","year":"2012","unstructured":"Vilalta R, Lara E, Madrid A, Chocron S, Munoz M, Casquero A, Nieto J (2012) Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr Nephrol 27:2323\u20132326","journal-title":"Pediatr Nephrol"},{"key":"3369_CR33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMc1308826","volume":"369","author":"T Ring","year":"2013","unstructured":"Ring T (2013) Eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 369:1377\u20131378","journal-title":"N Engl J Med"},{"key":"3369_CR34","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00467-013-2559-8","volume":"29","author":"SA Johnson","year":"2014","unstructured":"Johnson SA, Wong EK, Taylor CM (2014) Making sense of the spectrum of glomerular disease associated with complement dysregulation. Pediatr Nephrol 29:1883\u20131894","journal-title":"Pediatr Nephrol"},{"key":"3369_CR35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536","journal-title":"Nat Genet"},{"key":"3369_CR36","unstructured":"Modern Medicine Network. Formulary Watch. Available at: http:\/\/formularyjournal.modernmedicine.com\/formulary-journal\/news\/clinical\/clinical-pharmacology\/eculizumab?page=full Accessed 5 August 2015"},{"key":"3369_CR37","first-page":"459","volume":"57","author":"D Westra","year":"2012","unstructured":"Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP (2012) Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene. J Am Genet 57:459\u2013464","journal-title":"J Am Genet"},{"key":"3369_CR38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00431-012-1763-z","volume":"171","author":"RL Ruebner","year":"2012","unstructured":"Ruebner RL, Kaplan BS, Copelovitch L (2012) A time for reappraisal of \u201catypical\u201d hemolytic uremic syndrome: should all patients be treated the same? Eur J Pediatr 171:1519\u20131525","journal-title":"Eur J Pediatr"},{"key":"3369_CR39","doi-asserted-by":"crossref","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:E1445\u2013E1460","DOI":"10.1002\/humu.21256"},{"key":"3369_CR40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschenes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562","journal-title":"Clin J Am Soc Nephrol"},{"key":"3369_CR41","doi-asserted-by":"crossref","unstructured":"Sullivan M, Erlic Z, Hoffmann MM, Arbeiter K, Patzer L, Budde K, Hoppe B, Zeier M, Lhotta K, Rybicki LA, Bock A, Berisha G, Neumann HP (2010) Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Ann Hum Genet 74:17\u201326","DOI":"10.1111\/j.1469-1809.2009.00554.x"},{"key":"3369_CR42","doi-asserted-by":"crossref","unstructured":"Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12:297\u2013307","DOI":"10.1681\/ASN.V122297"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3369-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3369-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T15:29:06Z","timestamp":1655652546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,2]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3369"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3369-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,2]]}}}